---
title: Dr. Dilsher Dhoot — drug & device company payments (CMS Open Payments 2024)
license: CC0-1.0
source: CMS Open Payments PY2024 (Sunshine Act)
---

# Dr. Dilsher Dhoot — drug & device company payments (CMS Open Payments 2024)

CMS Open Payments PY2024 records for Dr. Dilsher Dhoot (Retina Specialist, SANTA BARBARA, CA, NPI 1508070566): $387,860 total across 330 payments from drug and device companies. Split by relevance: $387,860 promotional (marketing), $0 royalty/ownership, $0 research/other. Largest payers: Ocular Therapeutix, Inc. ($694,721), Apellis Pharmaceuticals, Inc. ($324,286), Genentech, Inc. ($260,666). Source: Sunshine Act. CC0.

## Claims

### Total 2024 industry payments to Dr. Dilsher Dhoot

**RECORDED.** In 2024, drug and device companies reported $387,860 in payments to Dr. Dilsher Dhoot (Retina Specialist, SANTA BARBARA, CA) across 330 payments.

Source: CMS Open Payments PY2024 (Sunshine Act) — https://openpaymentsdata.cms.gov/
Falsifier: A RECORD of measured/reported events (occurred=true) from CMS Open Payments PY2024 (Sunshine Act); superseded when CMS Open Payments PY2024 (Sunshine Act) publishes its next release.

### Payment composition: promotional vs royalty vs other

**INTERPRETATION.** Of that, $387,860 is promotional (meals, speaking, travel, consulting — a company marketing its products), $0 is royalty/ownership (income for inventing or owning something, not a prescribing conflict), and $0 is research/grants/other.

Source: Atlas Commons grouping of CMS nature-of-payment codes by patient relevance — https://care-atlas.ryanjhunter.workers.dev/
Falsifier: occurred=FALSE (a framing, not an event) and adjudged=FALSE (an in-house reading, not an authority's verdict) — the LOWEST-warrant claim here. A flat representation would render this identically to the official facts; the four-status does not.

### Largest paying companies (in-house ranking over CMS records)

**DERIVED.** Largest paying companies: Ocular Therapeutix, Inc. ($694,721), Apellis Pharmaceuticals, Inc. ($324,286), Genentech, Inc. ($260,666), Regeneron Healthcare Solutions, Inc. ($118,423), Alimera Sciences, Inc. ($78,425). The company names and per-payment amounts are CMS-recorded; the "largest" ranking and selection are an in-house aggregation, so adjudged=FALSE — CMS did not adjudge this ranking.

Source: Atlas Commons ranking over CMS Open Payments PY2024 by-company records — https://openpaymentsdata.cms.gov/
Falsifier: occurred=FALSE (a calculation, not an event) and adjudged=FALSE (a transparent in-house formula, not an authority's verdict — no external adjudicator). Reproduce it from its named inputs; falsified if the formula or inputs are wrong. Lower warrant than the adjudged figures above.

### What an Open Payments figure is — and is NOT

**INTERPRETATION.** A disclosed Open Payments amount is a publicly-reported financial relationship; it is not proof of wrongdoing and not evidence it changed patient care. It is not a rating of this physician.

Source: Sunshine Act transparency purpose; Atlas Commons L5 boundary — https://care-atlas.ryanjhunter.workers.dev/
Falsifier: occurred=FALSE (a framing, not an event) and adjudged=FALSE (an in-house reading, not an authority's verdict) — the LOWEST-warrant claim here. A flat representation would render this identically to the official facts; the four-status does not.

---

Every claim above carries a four-status warrant (RECORDED / MODELED / DERIVED / INTERPRETATION) and a named source you can re-fetch — this is a research object, not a flat fact. Structured: `https://care-atlas.ryanjhunter.workers.dev/payments/1508070566.jsonld`

## Data

### 2024 payment summary — Dr. Dilsher Dhoot

CMS Open Payments PY2024. Nature split (INTERPRETATION) is Atlas Commons grouping, not a CMS category.

| Category | Amount | Warrant |
| --- | --- | --- |
| Total payments | $387,860 | RECORDED |
| Promotional | $387,860 | INTERPRETATION |
| Royalty / ownership | $0 | INTERPRETATION |
| Research / other | $0 | INTERPRETATION |

### Largest paying companies

In-house ranking over CMS records (DERIVED). Company names and amounts are CMS-RECORDED.

| Company | Amount paid (2024) | Warrant |
| --- | --- | --- |
| Ocular Therapeutix, Inc. | $694,721 | DERIVED |
| Apellis Pharmaceuticals, Inc. | $324,286 | DERIVED |
| Genentech, Inc. | $260,666 | DERIVED |
| Regeneron Healthcare Solutions, Inc. | $118,423 | DERIVED |
| Alimera Sciences, Inc. | $78,425 | DERIVED |

### Payments by CMS nature-of-payment code

CMS-reported nature codes (RECORDED).

| Nature | Code | Amount | Warrant |
| --- | --- | --- | --- |
| Speaking / services (non-CE) | 2 | $189,038 | RECORDED |
| Consulting fees | 1 | $145,888 | RECORDED |
| Travel & lodging | 7 | $26,732 | RECORDED |
| Honoraria | 3 | $18,040 | RECORDED |
| Food & beverage | 6 | $8,154 | RECORDED |
| Education | 8 | $8 | RECORDED |